Terry invests in venture and growth-oriented companies with a focus on the healthcare space.
Before joining the firm, he was with Trinity Ventures, Ltd. He spent five years as a management consultant, including experience with the Boston Consulting Group, an international strategy consulting firm. He also has experience as a founder and executive in two successful entrepreneurial companies.
Terry is a member of Adams Street’s Growth Equity Investment Committee.
Aptinyx, Corvus, Fusion Pharmaceuticals, Millendo, Orbus, Outpost Medicine, Partner Therapeutics, and Qpex Biopharma
Atox Bio, CombiChem, Heartport, Icosavax, Incline Therapeutics, INC Research, Jazz Pharmaceuticals, Naurex Pharmaceuticals, NxStage Medical, Pharmacyclics, Proteus Digital Health, Rempex Pharmaceuticals, Revivant, Spinal Dynamics, and Vivant Medical